Folic acid supplementation and interpregnancy interval

Paediatric and Perinatal Epidemiology

Volumn 28, Issue 3, 2014, Pages 270-274

  Nilsen, Roy Miodini ^a,d   Mastroiacovo, Pierpaolo ^d   Gunnes, Nina ^c   Alsaker, Elin R ^c   Bjørke Monsen, Anne Lise ^b   Eussen, Simone J P M ^a,e   Haugen, Margaretha ^c   Johannessen, Ane ^b   Meltzer, Helle Margrete ^c   Stoltenberg, Camilla ^a   Ueland, Per Magne ^a   Vollset, Stein Emil ^a,c  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d Alessandra Lisi International Centre on Birth Defects and Prematurity   (Italy)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

cohort; folate; interpregnancy interval; pregnancy; vitamins

Indexed keywords

FOLIC ACID; VITAMIN;

ADOLESCENT; ADULT; ARTICLE; EDUCATION; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SMOKING; PREGNANCY; PREMATURE LABOR; PROSPECTIVE STUDY; SIBLING; TERM BIRTH; VITAMIN SUPPLEMENTATION; CAUCASIAN; COMPLICATION; DIET SUPPLEMENTATION; DIET THERAPY; EPIDEMIOLOGY; FAMILY PLANNING; FOLIC ACID DEFICIENCY; FOLLOW UP; MALE; MATERNAL CARE; NEURAL TUBE DEFECTS; NEWBORN; NORWAY; PREMATURITY;

ADULT; BIRTH INTERVALS; DIETARY SUPPLEMENTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; MALE; NEURAL TUBE DEFECTS; NORWAY; PRECONCEPTION CARE; PREGNANCY; PREMATURE BIRTH; PROSPECTIVE STUDIES; VITAMINS;

EID: 84897997890     PISSN: 02695022     EISSN: 13653016     Source Type: Journal    
DOI: 10.1111/ppe.12111     Document Type: Article

References (22)

1. Eichholzer M, Tonz O, Zimmermann R,. Folic acid: a public-health challenge. Lancet 2006; 367: 1352-1361.
2. Botto LD, Lisi A, Robert-Gnansia E, Erickson JD, Vollset SE, Mastroiacovo P, et-al. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? British Medical Journal 2005; 330: 571.
3. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, et-al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. New England Journal of Medicine 1999; 341: 1485-1490.
4. Czeizel AE, Dudas I,. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. New England Journal of Medicine 1992; 327: 1832-1835.
5. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338: 131-137.
6. Timmermans S, Jaddoe VW, Mackenbach JP, Hofman A, Steegers-Theunissen RP, Steegers EA,. Determinants of folic acid use in early pregnancy in a multi-ethnic urban population in the Netherlands: the Generation R study. Preventive Medicine 2008; 47: 427-432.
7. Nilsen RM, Vollset SE, Gjessing HK, Magnus P, Meltzer HM, Haugen M, et-al. Patterns and predictors of folic acid supplement use among pregnant women: the Norwegian Mother and Child Cohort Study. American Journal of Clinical Nutrition 2006; 84: 1134-1141.
8. Megahed MA, Taher IM,. Folate and homocysteine levels in pregnancy. British Journal of Biomedical Science 2004; 61: 84-87.
9. Doyle W, Srivastava A, Crawford MA, Bhatti R, Brooke Z, Costeloe KL,. Inter-pregnancy folate and iron status of women in an inner-city population. British Journal of Nutrition 2001; 86: 81-87.
10. Smits LJ, Essed GG,. Short interpregnancy intervals and unfavourable pregnancy outcome: role of folate depletion. Lancet 2001; 358: 2074-2077.
11. van Eijsden M, Smits LJ, van der Wal MF, Bonsel GJ,. Association between short interpregnancy intervals and term birth weight: the role of folate depletion. American Journal of Clinical Nutrition 2008; 88: 147-153.
12. King JC,. The risk of maternal nutritional depletion and poor outcomes increases in early or closely spaced pregnancies. Journal of Nutrition 2003; 133: 1732S-1736S.
13. Magnus P, Irgens LM, Haug K, Nystad W, Skjaerven R, Stoltenberg C, et-al. Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa). International Journal of Epidemiology 2006; 35: 1146-1150.
14. Nilsen RM, Vollset SE, Gjessing HK, Skjaerven R, Melve KK, Schreuder P, et-al. Self-selection and bias in a large prospective pregnancy cohort in Norway. Paediatric and Perinatal Epidemiology 2009; 23: 597-608.
15. Nilsen RM, Suren P, Gunnes N, Alsaker ER, Bresnahan M, Hirtz D, et-al. Analysis of self-selection bias in a population-based cohort study of autism spectrum disorders. Paediatric and Perinatal Epidemiology 2013; 27: 553-563.
16. Gunnes N, Suren P, Bresnahan M, Hornig M, Lie KK, Lipkin WI, et-al. Interpregnancy interval and risk of autistic disorder. Epidemiology (Cambridge, Mass.) 2013; 24: 906-912.
17. Scholl TO, Johnson WG,. Folic acid: influence on the outcome of pregnancy. American Journal of Clinical Nutrition 2000; 71: 1295S-1303S.
18. Milman N, Byg KE, Hvas AM, Bergholt T, Eriksen L,. Erythrocyte folate, plasma folate and plasma homocysteine during normal pregnancy and postpartum: a longitudinal study comprising 404 Danish women. European Journal of Haematology 2006; 76: 200-205.
19. Kwon S, Lazo-Escalante M, Villaran MV, Li CI,. Relationship between interpregnancy interval and birth defects in Washington State. Journal of Perinatology 2012; 32: 45-50.
20. Gunawardana L, Smith GD, Zammit S, Whitley E, Gunnell D, Lewis S, et-al. Pre-conception inter-pregnancy interval and risk of schizophrenia. British Journal of Psychiatry 2011; 199: 338-339.
21. Ray JG, Singh G, Burrows RF,. Evidence for suboptimal use of periconceptional folic acid supplements globally. British Journal of Obstetrics and Gynaecology 2004; 111: 399-408.
22. Daltveit AK, Vollset SE, Lande B, Oien H,. Changes in knowledge and attitudes of folate, and use of dietary supplements among women of reproductive age in Norway 1998-2000. Scandinavian Journal of Public Health 2004; 32: 264-271.